Osel Devices Ltd.
•₹ 400.554.27%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 48.1%
- Company has a healthy return on capital (ROCE) of 40.2%
- Operating margins have improved to 17.9% from 7.2%
- Company comfortably covers its interest (9.3x coverage)
- Attractively priced for its growth - PEG of 0.2
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.96x)
- Equity base is being diluted - shares outstanding up 766.7%
- Working capital days have increased from 41 to 180 days
- Total debt has risen sharply - up 94.8% year on year
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | LENSKART | 654.40 | 173.67 | 113820.20 | 0.00 | 2284.30 | 3634.35 | 27141.80 | 1332.69 | 12.55 | 21.70 |
| 2. | POLYMED | 1766.40 | 56.82 | 17904.49 | 0.20 | 85.27 | -8.39 | 525.38 | 30.30 | 14.05 | 24.11 |
| 3. | MOLBIO | 1032.40 | 71.42 | 11897.38 | 0.00 | — | — | — | — | 19.79 | — |
| 4. | LAXMIDENTL | 199.35 | 35.51 | 1096.85 | 0.00 | 10.32 | 23.83 | 74.70 | 16.13 | 24.96 | 20.26 |
| 5. | 3BBLACKBIO | 1138.50 | 17.60 | 977.14 | 0.44 | 8.98 | -28.99 | 33.49 | 50.59 | 26.03 | 25.45 |
| 6. | OSELDEVICE | 384.15 | 23.40 | 683.58 | 0.00 | — | — | — | — | 31.15 | — |
| 7. | GKB | 61.90 | 9.62 | 31.20 | 0.00 | 1.85 | 387.99 | 33.04 | 2.26 | 8.82 | 7.97 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 57 | 65 | 82 | 132 | 186 | |
| 55 | 61 | 73 | 110 | 153 | |
| Operating Profit | 3 | 5 | 9 | 23 | 34 |
| OPM % | 5 | 7 | 11 | 17 | 18 |
| Other Income | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 3 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| 2 | 3 | 7 | 19 | 29 | |
| Tax % | 33 | 29 | 33 | 32 | 31 |
| Net Profit | 1 | 2 | 5 | 13 | 20 |
| EPS | 10 | 11 | 25 | 11 | 12 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 2 | 4 | 11 | 12 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 2 | 4 | 11 | 12 |
Mar 2021
- 57
- 55
- Operating Profit
- 3
- OPM %
- 5
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 2
- Tax %
- 33
- Net Profit
- 1
- EPS
- 10
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2022
- 65
- 61
- Operating Profit
- 5
- OPM %
- 7
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 3
- Tax %
- 29
- Net Profit
- 2
- EPS
- 11
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2023
- 82
- 73
- Operating Profit
- 9
- OPM %
- 11
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 7
- Tax %
- 33
- Net Profit
- 5
- EPS
- 25
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2024
- 132
- 110
- Operating Profit
- 23
- OPM %
- 17
- Other Income
- 0
- Interest
- 3
- Depreciation
- 1
- 19
- Tax %
- 32
- Net Profit
- 13
- EPS
- 11
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
Mar 2025
- 186
- 153
- Operating Profit
- 34
- OPM %
- 18
- Other Income
- 0
- Interest
- 3
- Depreciation
- 1
- 29
- Tax %
- 31
- Net Profit
- 20
- EPS
- 12
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 42%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 111%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -17%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 41%
- 3 Years:
- 48%
- Last Year:
- 30%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 1 | 2 | 2 | 12 | 16 |
| 4 | 6 | 10 | 14 | 92 | |
| 7 | 7 | 16 | 16 | 47 | |
| Trade Payables | 5 | 15 | 16 | 36 | 30 |
| 6 | 3 | 5 | 21 | 12 | |
| Total Liabilities | 23 | 33 | 49 | 99 | 198 |
| ASSETS | - | - | - | - | - |
| 6 | 5 | 7 | 18 | 17 | |
| 4 | 10 | 18 | 25 | 41 | |
| 0 | 0 | 0 | 27 | 66 | |
| Cash & Bank | 5 | 5 | 1 | 1 | 9 |
| 8 | 12 | 23 | 27 | 65 | |
| Total Assets | 23 | 33 | 49 | 99 | 198 |
| Total Debt | 10 | 9 | 18 | 25 | 50 |
| Net Working Capital | 3 | 4 | 7 | 15 | 92 |
| Contingent Liabilities | 0 | 0 | 0 | 1 | 0 |
| Book Value per Share | 36.79 | 41.00 | 66.04 | 21.96 | 66.93 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 10 | 9 | 18 | 25 | 50 |
| Net Working Capital | 3 | 4 | 7 | 15 | 92 |
| Contingent Liabilities | 0 | 0 | 0 | 1 | 0 |
| Book Value per Share | 36.79 | 41.00 | 66.04 | 21.96 | 66.93 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 1
- 4
- 7
- Trade Payables
- 5
- 6
- Total Liabilities
- 23
- 6
- 4
- 0
- Cash & Bank
- 5
- 8
- Total Assets
- 23
- Total Debt
- 10
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 36.79
- Face Value
- 10.00
- Total Debt
- 10
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 36.79
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 2
- 6
- 7
- Trade Payables
- 15
- 3
- Total Liabilities
- 33
- 5
- 10
- 0
- Cash & Bank
- 5
- 12
- Total Assets
- 33
- Total Debt
- 9
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 41.00
- Face Value
- 10.00
- Total Debt
- 9
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 41.00
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 2
- 10
- 16
- Trade Payables
- 16
- 5
- Total Liabilities
- 49
- 7
- 18
- 0
- Cash & Bank
- 1
- 23
- Total Assets
- 49
- Total Debt
- 18
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 66.04
- Face Value
- 10.00
- Total Debt
- 18
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 66.04
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 12
- 14
- 16
- Trade Payables
- 36
- 21
- Total Liabilities
- 99
- 18
- 25
- 27
- Cash & Bank
- 1
- 27
- Total Assets
- 99
- Total Debt
- 25
- Net Working Capital
- 15
- Contingent Liabilities
- 1
- Book Value per Share
- 21.96
- Face Value
- 10.00
- Total Debt
- 25
- Net Working Capital
- 15
- Contingent Liabilities
- 1
- Book Value per Share
- 21.96
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 16
- 92
- 47
- Trade Payables
- 30
- 12
- Total Liabilities
- 198
- 17
- 41
- 66
- Cash & Bank
- 9
- 65
- Total Assets
- 198
- Total Debt
- 50
- Net Working Capital
- 92
- Contingent Liabilities
- 0
- Book Value per Share
- 66.93
- Face Value
- 10.00
- Total Debt
- 50
- Net Working Capital
- 92
- Contingent Liabilities
- 0
- Book Value per Share
- 66.93
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -3 | 3 | -11 | 13 | -38 | |
| Cash from Investing | 0 | 0 | -2 | -13 | -0 |
| Cash from Financing | 5 | -2 | 8 | 4 | 53 |
| 2 | 1 | -4 | 4 | 14 | |
| Free Cash Flow | -3 | 2 | -12 | 0 | -38 |
| OCF / Net Profit | -2.45 | 1.21 | -2.29 | 1.02 | -1.91 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -2.45 | 1.21 | -2.29 | 1.02 | -1.91 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- -3
- Cash from Investing
- 0
- Cash from Financing
- 5
- 2
- Free Cash Flow
- -3
- OCF / Net Profit
- -2.45
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.45
- Cumulative 5-Year FCF
- 0
Mar 2022
- 3
- Cash from Investing
- 0
- Cash from Financing
- -2
- 1
- Free Cash Flow
- 2
- OCF / Net Profit
- 1.21
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.21
- Cumulative 5-Year FCF
- 0
Mar 2023
- -11
- Cash from Investing
- -2
- Cash from Financing
- 8
- -4
- Free Cash Flow
- -12
- OCF / Net Profit
- -2.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.29
- Cumulative 5-Year FCF
- 0
Mar 2024
- 13
- Cash from Investing
- -13
- Cash from Financing
- 4
- 4
- Free Cash Flow
- 0
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 0
Mar 2025
- -38
- Cash from Investing
- -0
- Cash from Financing
- 53
- 14
- Free Cash Flow
- -38
- OCF / Net Profit
- -1.91
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.91
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | 9.99 | 11.41 | 25.04 | 10.99 | 12.43 |
| Book Value (₹) | 36.79 | 41.00 | 66.04 | 21.96 | 66.93 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 2.22 | 2.33 | 4.54 | 11.82 | 13.11 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 5.27% | 7.18% | 10.63% | 17.01% | 17.92% |
| Net Margin % | 2.37% | 3.25% | 5.69% | 9.59% | 10.75% |
| ROE % | 27.16% | 33.60% | 46.79% | 67.41% | 30.09% |
| ROCE % | 16.95% | 26.49% | 35.05% | 54.36% | 31.15% |
| 6.03% | 7.62% | 11.35% | 17.18% | 13.53% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 45 | 51 | 54 | 54 | 90 |
| Inventory Days | 25 | 40 | 63 | 60 | 65 |
| Payable Days | 37 | 64 | 83 | 94 | 85 |
| 33 | 27 | 34 | 20 | 70 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 1.97x | 1.13x | 1.45x | 1.00x | 0.46x |
| Interest Coverage (x) | 5.02x | 3.63x | 7.01x | 6.38x | 9.32x |
| 1.18x | 1.17x | 1.20x | 1.23x | 2.05x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 13.58% | 25.51% | 61.48% | 41.01% |
| Operating Profit Growth % | 0.00% | 54.62% | 85.99% | 163.46% | 46.18% |
| Net Profit Growth % | 0.00% | 56.10% | 119.49% | 172.19% | 58.09% |
| 0.00% | 0.00% | 0.00% | -56.10% | 13.09% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 19.47x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 3.62x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 1.55x | 12.86x |
Mar 2021
- EPS (₹)
- 9.99
- Book Value (₹)
- 36.79
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.22
- Operating Margin %
- 5.27%
- Net Margin %
- 2.37%
- ROE %
- 27.16%
- ROCE %
- 16.95%
- 6.03%
- Debtor Days
- 45
- Inventory Days
- 25
- Payable Days
- 37
- 33
- Debt to Equity (x)
- 1.97x
- Interest Coverage (x)
- 5.02x
- 1.18x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 11.41
- Book Value (₹)
- 41.00
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.33
- Operating Margin %
- 7.18%
- Net Margin %
- 3.25%
- ROE %
- 33.60%
- ROCE %
- 26.49%
- 7.62%
- Debtor Days
- 51
- Inventory Days
- 40
- Payable Days
- 64
- 27
- Debt to Equity (x)
- 1.13x
- Interest Coverage (x)
- 3.63x
- 1.17x
- Revenue Growth %
- 13.58%
- Operating Profit Growth %
- 54.62%
- Net Profit Growth %
- 56.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 25.04
- Book Value (₹)
- 66.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.54
- Operating Margin %
- 10.63%
- Net Margin %
- 5.69%
- ROE %
- 46.79%
- ROCE %
- 35.05%
- 11.35%
- Debtor Days
- 54
- Inventory Days
- 63
- Payable Days
- 83
- 34
- Debt to Equity (x)
- 1.45x
- Interest Coverage (x)
- 7.01x
- 1.20x
- Revenue Growth %
- 25.51%
- Operating Profit Growth %
- 85.99%
- Net Profit Growth %
- 119.49%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 10.99
- Book Value (₹)
- 21.96
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 11.82
- Operating Margin %
- 17.01%
- Net Margin %
- 9.59%
- ROE %
- 67.41%
- ROCE %
- 54.36%
- 17.18%
- Debtor Days
- 54
- Inventory Days
- 60
- Payable Days
- 94
- 20
- Debt to Equity (x)
- 1.00x
- Interest Coverage (x)
- 6.38x
- 1.23x
- Revenue Growth %
- 61.48%
- Operating Profit Growth %
- 163.46%
- Net Profit Growth %
- 172.19%
- -56.10%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.55x
Mar 2025
- EPS (₹)
- 12.43
- Book Value (₹)
- 66.93
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.11
- Operating Margin %
- 17.92%
- Net Margin %
- 10.75%
- ROE %
- 30.09%
- ROCE %
- 31.15%
- 13.53%
- Debtor Days
- 90
- Inventory Days
- 65
- Payable Days
- 85
- 70
- Debt to Equity (x)
- 0.46x
- Interest Coverage (x)
- 9.32x
- 2.05x
- Revenue Growth %
- 41.01%
- Operating Profit Growth %
- 46.18%
- Net Profit Growth %
- 58.09%
- 13.09%
- P/E (x)
- 19.47x
- P/B (x)
- 3.62x
- Dividend Yield %
- 0.00%
- 12.86x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Jun 2026
Nov 2025
Aug 2025

